Archives
-
Q-VD-OPh: Potent Pan-Caspase Inhibitor for Apoptosis Researc
2026-05-17
Q-VD-OPh is a potent, selective, and irreversible pan-caspase inhibitor used to dissect apoptotic pathways in both in vitro and in vivo models. Its nanomolar activity against multiple caspases enables precise inhibition of cell death, facilitating studies in apoptosis, neurodegenerative disease, and cell viability post-cryopreservation.
-
NMDA (N-Methyl-D-aspartic acid): Enabling Next-Gen Retinal N
2026-05-13
Explore how NMDA (N-Methyl-D-aspartic acid) advances retinal neurodegeneration research by enabling precise modeling of excitotoxicity and ferroptosis. Discover unique insights into assay design and translational relevance, grounded in the latest breakthroughs.
-
CDK4/6 and BET Inhibitor Synergy Suppresses PDAC via Wnt/β-c
2026-05-12
Gu et al. (2025) demonstrate that dual inhibition of CDK4/6 and BET proteins in pancreatic ductal adenocarcinoma (PDAC) models synergistically suppresses tumor growth and reverses EMT by targeting the GSK3β-mediated Wnt/β-catenin pathway. This mechanistic insight supports rational combination strategies for difficult-to-treat PDAC.
-
AZD0156: Potent ATM Kinase Inhibitor for DNA Damage Research
2026-05-11
AZD0156 is a highly selective ATM kinase inhibitor that enables precise modulation of the DNA damage response, with sub-nanomolar potency and over 1000-fold selectivity. It shows synergy with DNA damaging agents in preclinical cancer models, making it an important tool for cancer therapy research and checkpoint control studies.
-
Calpeptin: Precision Calpain Inhibitor for Fibrosis Research
2026-05-09
Calpeptin stands out as a potent calpain inhibitor, enabling researchers to dissect pathways in fibrosis, inflammation, and regulated cell death with high selectivity and robust performance. Its nanomolar potency, excellent solubility in DMSO/ethanol, and consistent results across in vitro and in vivo models make it indispensable for pulmonary fibrosis and advanced cell biology research.
-
MHY1485: mTOR Activator for Precision Autophagy Assays
2026-05-08
MHY1485 offers precise, reproducible control of the mTOR signaling pathway, setting the standard for autophagy inhibition in cell biology and ovarian follicle development research. This article delivers protocol-driven guidance, workflow optimization, and troubleshooting insights for leveraging MHY1485 from APExBIO in advanced experimental designs.
-
Cediranib (AZD2171) for Advanced In Vitro Angiogenesis Resea
2026-05-06
Cediranib (AZD2171) delivers high-fidelity VEGFR inhibition for cancer research, enabling precise dissection of angiogenesis and PI3K/Akt/mTOR signaling in vitro. This guide details optimized workflows, actionable troubleshooting advice, and practical insights from recent methodological advances, helping researchers achieve reproducible and interpretable results.
-
Caspase-3/NDUFS1 Axis Drives Trichothecene-Induced Mitochond
2026-05-05
This study reveals that caspase-3-mediated cleavage of mitochondrial NDUFS1 is a pivotal driver of reactive oxygen species (ROS) accumulation and mitochondrial dysfunction following trichothecene exposure. The discovery of a positive feedback loop involving mitochondrial and ER-derived ROS not only clarifies the molecular basis of trichothecene hepatotoxicity but also highlights new therapeutic targets for mitigating mycotoxin-induced liver injury.
-
AZD0156 and ATM Kinase Inhibition: Metabolic Rewiring in Can
2026-05-04
Explore how AZD0156, a potent ATM kinase inhibitor, drives metabolic adaptation and unveils new vulnerabilities in cancer research. This article uniquely focuses on the intersection of DNA damage response inhibition and tumor cell metabolism.
-
Deferasirox Fe3+ Chelate: Applied Workflows for Iron Overloa
2026-05-03
Deferasirox Fe3+ chelate empowers researchers with high-affinity, DMSO-soluble iron chelation, enabling precise modeling of iron overload in beta-thalassemia and chronic anemia studies. This guide spotlights APExBIO’s reagent in practical protocols, troubleshooting, and advanced use-cases, translating clinical pharmacology insights into robust experimental workflows.
-
3-Bromopyruvate and Cetuximab: Overcoming CRC Resistance via
2026-05-02
The study by Mu et al. demonstrates that combining 3-bromopyruvate with cetuximab overcomes drug resistance in colorectal cancer (CRC) cells by triggering autophagy-dependent ferroptosis and apoptosis. These mechanistic insights offer promising directions for overcoming resistance in targeted CRC therapies.
-
OM-MSCs Mitigate Golgi Stress After Cerebral Ischemia via PI
2026-05-01
This study demonstrates that olfactory mucosa mesenchymal stem cells (OM-MSCs) protect against Golgi apparatus stress following cerebral ischemia/reperfusion injury by activating the PEDF-PI3K/Akt/mTOR signaling pathway. These findings provide mechanistic insight into stem cell-based neuroprotection and suggest actionable targets for future cerebral ischemia interventions.
-
Scenario-Driven Solutions with KU-60019: ATM Kinase Inhibito
2026-05-01
This article distills practical, scenario-based guidance for biomedical researchers and lab technicians using KU-60019 (SKU A8336) as a potent ATM kinase inhibitor. Drawing on validated protocols, quantitative data, and peer-reviewed research, it addresses key challenges in assay reproducibility, radiosensitization workflows, and product selection. The evidence-based analysis highlights how KU-60019 supports robust, reproducible results in glioma and DNA damage response studies.
-
Erastin (SKU B1524): Reliable Ferroptosis Inducer for Cancer
2026-04-30
This article addresses lab challenges in ferroptosis research and cancer biology by examining how Erastin (SKU B1524) from APExBIO offers reproducible, data-backed solutions. Practical Q&A blocks cover assay design, protocol optimization, comparative vendor reliability, and data interpretation, highlighting Erastin's performance, selectivity, and workflow compatibility.
-
Q-VD-OPh: Precision Pan-Caspase Inhibition in Neurobiology
2026-04-29
Explore how Q-VD-OPh, a potent pan-caspase inhibitor, transforms apoptosis research and neurodegeneration studies. This article provides a deeper scientific perspective on mechanism, selectivity, and assay optimization.
449 records 9/30 page Previous Next First page 上5页 678910 下5页 Last page